APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems.
Girolami
A
A
Simioni
P
P
Tormene
D
D
D020016:Activated Protein C Resistance / Q000150:complications* / Q000453:epidemiology; D000991:Antithrombins / Q000172:deficiency; D003276:Contraceptives, Oral / Q000009:adverse effects*; D000075202:Contraindications; D005165:Factor V / Q000009:adverse effects / Q000235:genetics; D005260:Female; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D017354:Point Mutation; D015995:Prevalence; D012307:Risk Factors; D020246:Venous Thrombosis / Q000139:chemically induced* / Q000453:epidemiology / Q000235:genetics
D000991:Antithrombins; D003276:Contraceptives, Oral; C095381:factor V Leiden; D005165:Factor V